Patent · US Expired

Use of cyclopentabenzofuran-derivatives for combating (NF-&kgr;B)-dependent diseases

US6518274B1 · kind B1 · utility

2Cited by

1References

9Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Matthias Gehling · Leichlingen, DE
Jorg Baumgarten · Wuppertal, DE
Axel Kretschmer · Wuppertal, DE
Horst-Peter Antonicek · Bensberg, DE
Peter Proksch · Jülich, DE
Bambang Wahyu Nugroho · Bogor, ID
Frank Bohnenstengel · Fürth, DE

Key dates

Filing date	Apr 18, 2001
Grant date	Feb 11, 2003
Priority date	—
Expiry date	Apr 18, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of cycloventabenzofuran derivatives for the production of a medicament for the treatment of nuclear factor of &kgr;B-dependent diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.